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Redundant Regulation of T Cell Differentiation
and TCRa Gene Expression by the Transcription
Factors LEF-1 and TCF-1
pre-T cell receptor complex (Saint-Ruf et al., 1994). Tar-
geted disruptions of the TCRb and pTa genes have
shown that the pre-TCR complex is important for the
generation of a/b T cells (Mombaerts et al., 1992; Fehling
et al., 1995). Cells that fail to express a functional pre-
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Differentiation of TCRa/b-expressing cells continuesUniversity Hospital
3508 GA Utrecht with the appearance of CD8 on the cell surface, produc-
ing cells termed immature CD81 single-positive (ISP)The Netherlands
cells. These cells differentiate into CD41CD81 double-
positive (DP) cells, which again up-regulate the Rag1
and Rag2 genes and rearrange the TCRa locus. Finally,Summary
the DP cells undergo selection to produce either CD41
CD82 or CD42CD81 mature single-positive (MSP) cells.Lymphoid enhancer factor 1 (LEF-1) and T cell factor
Interest in the regulation of this complex differentia-1 (TCF-1) are closely related transcription factors that
tion process has prompted studies of the transcriptionalare both expressed during murine T cell differentiation
control of genes that are expressed in cell lineage± and/and that regulate theT cell receptor a (TCRa) enhancer
or differentiation stage±specific patterns. Within the Tin transfection assays. Targeted gene disruption of
cell lineages, several cell- and stage-specific transcrip-either the Tcf1 or Lef1 gene in mice did not affect
tion factors have been identified (reviewed by LeidenTCRa gene expression and resulted in an incomplete
and Thompson, 1994; Clevers and Grosschedl, 1996).defect or no defect in thymocyte differentiation. Here,
One family of transcription factors expressed in T lym-we examine a potential redundancy of these transcrip-
phocytes is the high-mobility group (HMG) family of pro-tion factors by analyzing double-mutant mice. In fetal
teins, which is characterized by a conserved DNA-bind-thymic organ cultures from Lef12/2Tcf12/2 mice, a/b T
ing motif, termed the HMG domain (reviewed by Laudetcell differentiation is completely arrested at the imma-
et al., 1993; Grosschedl et al., 1994). Two members ofture CD81 single-positive (CD81 ISP) stage and is
this family, lymphoid enhancer-binding factor 1 (LEF-1)markedly impaired at an earlier stage. In addition, we
and T cell factor 1 (TCF-1), contain nearly identical HMGfind that sorted CD81 ISP cells from Lef12/2Tcf12/2 mice
domains and share a high degree of homology through-express TCRb but show a severely reduced level of
out the rest of the protein (Oosterwegel et al., 1991;TCRa gene transcription. Together, these data show
Travis et al., 1991; van de Wetering et al., 1991, 1996;that LEF-1 and TCF-1 are redundant in the regulation
Waterman et al., 1991). LEF-1 was initially cloned asof T cell differentiation and gene expression.
a pre-B± and T lymphocyte±specific gene encoding a
protein that recognizes a 59 CTTTGAA motif in the TCRa
Introduction
gene enhancer and that stimulates the activity of this
enhancer in tissue culture transfection assays (Travis et
Differentiation of T lymphocytes in the thymus is an
al., 1991; Waterman et al., 1991). LEF-1 was found to
ordered process with multiple steps that can be defined
bind DNA through the minor groove and to bend theby the expression of specific cell surface antigens and
DNA helix, facilitating the assembly of a higher-orderintracellular proteins. T cell precursors that migrate into
multiprotein enhancer complex together with otherthe thymus are negative for most T cell surface antigens
lymphoid-specific proteins (Giese et al., 1992, 1995).butexpress low levels of CD4(Wu et al.,1991). Differenti-
TCF-1 was identified as a T cell±specific gene encodingation of these precursors generates thymocytes that are
a CD3e enhancer-binding protein (Oosterwegel et al.,negative for surface expression of both CD4 and CD8
1991; van de Wetering et al., 1991).(double negative [DN]). These cells include three distinct
LEF-1 and TCF-1 have virtually identical DNA bindingdifferentiation stages defined by ordered changes in
properties, and both activate the minimal TCRa en-the surface expression of CD44 and CD25 (reviewed by
hancer, although LEF-1 is approximately 10-fold moreGodfrey and Zlotnik, 1993). During the last DN stage
efficient in stimulating the TCRa enhancer than TCF-1(CD442CD251) of thymocyte differentiation, expression
(Travis et al., 1991; van de Wetering et al., 1991, 1996;of the Rag1 and Rag2 genes is up-regulated, and the
Waterman et al., 1991). Additional binding sites for LEF-1genes encoding the T cell receptor (TCR) b, d, and g
and TCF-1 have been identified in transcriptional controlchains are rearranged (Godfrey et al., 1994). Proteins
regions of several other T lymphocyte-specific genes,produced from productively rearranged TCRb genes
including those encoding adenosine deaminase (ADA)associate with pre-TCRa (pTa) chains, generating a
(Aronow et al., 1992; Brickner et al., 1995), CD4 (Sawada
and Littman, 1991), TCRb, and TCRd (Clevers et al.,
1993; Leiden, 1993). Both Lef1 and Tcf1 genes are ex-³To whom correspondence should be addressed (e-mail: rgross@
itsa.ucsf.edu). pressed at varying levels during T cell differentiation
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within the thymus and in mature peripheral T cells (Ver- mutant mice were further crossed to generate homozy-
gous double-mutant mice, which were born at normalbeek et al., 1995), although Tcf1 transcripts are signifi-
cantly more abundant than Lef1 transcripts (van de Wet- frequency but died at birth.
T cell differentiation in the thymi of mutant mice defi-ering et al., 1996).
Insight into the role of these transcription factors in cient in both LEF-1 and TCF-1 was analyzed in fetal
thymic organ cultures (Ramsdell, 1992). We removedvivo has been provided by the analysis of mice carrying
targeted mutations in either the Lef1 or Tcf1 gene (van the thymus from embryonic day 17.5 (E17.5) embryos,
which normally contain DN and DP immature T cells butGenderen et al., 1994; Verbeek et al., 1995). In LEF-
1±deficient mice, no abnormalities of thymocyte differ- lack the CD41 and CD81 MSP cells (Ramsdell, 1992).
We cultured the organs for 7 days to allow further differ-entiation aredetected, although the development of sev-
eral nonlymphoid organs is severely impaired and the entiation and generation of the mature T cells. The geno-
types of the embryos were determined by DNA blotmice die shortly after birth (van Genderen et al., 1994).
TCF-1±deficient mice display an incomplete block in analysis using tail genomic DNA (data not shown). The
viability of cells within the organ cultures was monitoredthymocyte differentiation, resulting in an accumulation
of CD81 ISP cells and a significant reduction of mature by fluorescence-activated cell sorter analysis using pro-
pidium iodide. Nonviable cultures were excluded, andT cells in the periphery (Verbeek et al., 1995). In addition,
extrathymic development of intestinal g/d and liver NK11 all experiments were performed in triplicate. Differentia-
tion of thymocytes in fetal thymic organ cultures wasT cells is impaired in Tcf12/2 mice (Ohteki et al., 1996).
The extent of these defects depends on the mutation examined by analysis of surface expression of CD4 and
CD8, TCRb and TCRg/d, and CD25 and CD44.of the Tcf1 gene and are more pronounced in Tcf(VII)
mice carrying a neo gene insertion in exon VII encoding The total number of thymocytes in thymic organ cul-
tures from Tcf1(V)2/2 embryos was approximately 50%part of the DNA-binding domain of TCF-1, than in Tcf(V)
mice in which exon V was mutated (Verbeek et al., 1995). of the number observed in cultures from normal mice.
This number of thymocytes was reduced further by aIn both LEF-1± and TCF-1±deficient mice, however, ex-
pression of the TCRa gene is found to be normal, raising factor of 14 in the Lef12/2Tcf1(V)2/2 organ cultures (Table
1). Analysis of thymocytes for surface expression of CD4the possibility of a genetic redundancy of the Lef1 and
Tcf1 genes. and CD8 indicated that the cultures from Lef12/2Tcf11/1
mice contained differentiating T cell populations similarIn this study, we analyzed the effects of mutations in
both Lef1 and Tcf1 genes on the differentiation of T to those of the control cultures (Figure 1). Consistent
lymphocytes. Fetal thymic organ cultures derived from with the phenotype in 1-month-old Tcf12/2 mice (Ver-
homozygous double-mutant embryos show a complete beek et al., 1995), fetal thymic organ cultures from both
block in T cell differentiation and a marked decrease in Tcf1(V)2/2 and Tcf1(VII)2/2 mutant mice showed an in-
TCRa expression, indicating that LEF-1 and TCF-1 can crease in the relative number of CD81 cells, and the
regulate these processes in an at least partially redun- Tcf1(VII)2/2 cultures showed a relative decrease in the
dant manner. number of CD41 cells. This defect in T cell differentiation
was significantly exacerbated in the Lef11/2Tcf1(V)2/2
Results organ cultures. In fetal thymic organ cultures from
Lef12/2Tcf1(V)2/2 mice, T cell differentiation was almost
completely blocked and contained virtually no CD41Redundant Regulation of a/b T Cell Differentiation
by LEF-1 and TCF-1 at the Immature CD82 and CD41CD81 T cells. Residual CD41CD82 cells
(1.4%) present in the fetal thymic organ cultures from theCD81 Single-Positive Stage
To examine whether LEF-1 and TCF-1 regulate T cell homozygous double-mutant mice expressed the NK1.1
surface antigen, which is characteristic of natural killerdifferentiation and gene expression in a redundant man-
ner, we generated mice carrying targeted mutations in cells (data not shown), and thus appear not to be con-
ventional mature CD41CD82 a/b T cells. The abundantboth genes. Given the perinatal lethality of the Lef12/2
mice (van Genderen et al., 1994), we crossed homozy- population of CD42CD81 T cells most likely represents
CD81 ISP cells because the majority of this populationgous Tcf1(V)2/2 mutant mice with heterozygous LEF-
1±deficient mice to avoid the possibility of an early em- did not display detectable surface expression of TCRb
(Figure 2).bryonic lethality. Double-heterozygous Lef11/2Tcf1(V)1/2
Table 1. Fetal Thymic Organ Culture Experiments
Genotype No. of Cultures T Cells Total Thymocytes T Cells
Wild type 7 2.76 3 105 3.7 3 105 74%
Lef12/2Tcf11/1 6 1.89 3 105 2.7 3 105 69%
Lef11/1Tcf1(V)2/2 4 1.26 3 105 1.7 3 105 74%
Lef11/2Tcf1(V)2/2 5 1.01 3 105 1.2 3 105 84%
Lef12/2Tcf1(V)2/2 5 8.48 3 103 1.2 3 104 68%
Thymus was isolated from E17.5 embryos and cultured at 378C for 7 days in supplemented RPMI. The numbers of total thymocytes were
determined by flow cytometry, using size and complexity gating and propidium iodine uptake to identify live cells. T cells were identified by
antibody staining against Thy1.2, CD4, and CD8. The number of T cells in Tcf12/2 fetal thymic organ cultures is reduced by a factor of 2±3
relative to control cultures, and the number of T cells in the Lef12/2Tcf1(V)2/2 fetal thymic organ cultures is reduced by a factor of 30. Standard
deviation of the number of total thymocytes was less than 50%, and the standard deviation of the percentage of T cells per culture was less
than 5%.
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Figure 1. Expression of Functional LEF-1
and TCF-1 Is Important for the Development
of DP T Cells
Two-color flow cytometry analysis of E17.5
fetal thymic organ cultures, after seven days
of culture, using antibodies against mouse
CD4 and CD8. Percentages of cell popula-
tions are calculated from total viable lympho-
cytes by gating according to size (forward
scatter) andcomplexity (side scatter). The ge-
notypes of the organ culture are indicated
above each panel. Each panel is representa-
tive of a minimum of three independent organ
cultures.
To examine whether the deficiency of LEF-1 and deficiency in both LEF-1 and TCF-1 has a major impact
on a/b T cell development but does not appear toTCF-1 affects both a/b and g/d T cell lineages, we ana-
lyzed the thymocytes for the expression of TCRb and strongly affect the differentiation of cells into the g/d T
cell lineage within fetal thymic organ culture.TCRg/d. Abundant TCRb surface expression was de-
tected in fetal thymic organ cultures from mice carrying
either single gene disruption, whereas the number of
TCRb-expressing cells in the homozygous double- Impairment of Early T Cell Differentiation in
Lef12/2Tcf1(V)2/2 Fetal Thymic Organ Culturesmutant cultures was reduced to only 6% of the total
thymus (Figure 2). The percentage of cells expressing With the aim of studying early stages of T cell differentia-
tion in more detail, we analyzed the expression of CD25TCRg/d on their cell surface was increased in cultures
from Tcf1(V)2/2 and Tcf1(VII)2/2 mutant mice by factors and CD44 on DN T cells that were defined by the ab-
sence of the markers CD3, CD4, CD8, B220, TCRg/d,of 2- and 5-fold, respectively. In Lef12/2Tcf1(V)2/2 fetal
thymic organ cultures, this effect was further accentu- and NK1.1. Wild-type, Lef12/2Tcf1(V)1/1, and Lef11/1
Tcf1(V)2/2 fetal thymic organ cultures were found to con-ated, increasing the percentage of g/d T cells to 33%.
The absolute number of g/d T cells, however, was re- tain similar proportions of cells representing the
CD442CD251 DN stage of T cell differentiation (Figureduced 2-fold. Taken together, these data indicate that
Figure 2. T Cell Differentiation in Lef12/2
Tcf1(V)2/2 Fetal Thymic Organ Cultures Is
Blocked in a/b but Not g/d T Cells
Two-color flow cytometry analysis of E17.5
fetal thymic organ cultures, after 7 days of
culture, using antibodies against mouse
TCRb and TCRg/d. g/d T cells are considered
cells that are positive only for TCRg/d stain-
ing, and a/b T cells are considered cells that
are positive only for TCRb staining.
Immunity
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Figure 3. Incomplete Block of T Cell Differentiation at the CD442CD251 DN Stage in Lef12/2Tcf1(V)2/2 Fetal Thymic Organ Cultures
Three-color flow cytometry analysis of E17.5 fetal thymic organ culture, after 7 days of culture, using antibodies against mouse CD44 and
CD25. DN cells were gated for a lack of detectable surface expression of B220, CD3, CD4, CD8, NK1.1 and TCRg/d. The three DN populations
(CD441CD252, CD441CD251, and CD442CD251) are indicated by rectangles, with the relative percentages of cells in each gate denoted. The
total number of DN cells in each thymic organ culture is indicated above the contour plots.
3). In the Lef12/2Tcf1(V) 2/2 thymic organ cultures, how- ure 4). In addition, CD4 expression was induced in
Lef12/2Tcf1(V)2/2 thymic organ cultures by the antibodyever, we observed a 3-fold increase in the proportion
of cells at this early developmental stage, suggesting stimulation (Figure 4). Thus, CD4 transcription may not
be dependent on the expression of LEF-1 and TCF-1,that LEF-1 and TCF-1 control, at least in part, this step
in T cell differentiation. despite the presence of a binding site in the murine CD4
enhancer (Sawada and Littman, 1991).To explore the possibility that the incomplete block
during the DN stage of differentiation was due toa defect
in pre-TCR signaling, we experimentally induced the LEF-1 and TCF-1 Affect T Cell Differentiation
fetal thymic organ cultures with anti-CD3e antibody in a T Cell±Autonomous Manner
(Levelt et al., 1993). Control organ cultures using thymi To determine whether peripheral T cells develop from
from newborn RAG-1±deficient animals did not differen- Lef12/2Tcf1(V)2/2 precursors, we performed adoptive
tiate beyond the DN stage, but the addition of anti-CD3e transfer experiments in SCID (severe combined immu-
antibody (145±2C11), triggered maturation to the DP nodeficiency) mice (Fulop and Phillips, 1986). We in-
stage (Figure 4). Lef12/2Tcf1(V)2/2 thymic organ cultures jected 1 3 107 E16.5 fetal liver cells intravenously into
were also able to respond to the anti-CD3e treatment SCID mice and analyzed peripheral blood, spleen, and
by differentiating into DP thymocytes, suggesting that thymus after 10 weeks. In all adoptive transfers, B cells
the signaling pathway used by the pre-T cell receptor were detected in both blood and spleen at normal num-
is not abrogated in the double-deficient animals (Fig- bers, confirming a successful reconstitution (Figure 5
and Table 2). By contrast, only 2 of 12 transfers of
Lef11/2Tcf12/2 fetal liver cells allowed thymic reconstitu-
tion of CD41 and CD81 MSP T cells (Figure 5 and Table
2). Notably, these two T cell reconstitutions did not gen-
erate any detectable peripheral T cells (Figure 5).
In adoptive transfers with fetal liver cells from
Lef12/2Tcf1(V)2/2 embryos, only 1 of 12 yielded partial
reconstitution of immature T lymphocytes within the thy-
mus, and none generated peripheral T cells (Figure 5
and Table 2). Thus, the dependence of T cell differentia-
tion on TCF-1 was more pronounced in the adoptive
transfer assay than in fetal thymic organ cultures, and
the defect was further exacerbated by the absence of
functional LEF-1 protein. In addition, the phenotype of T
cell differentiation in the single successful reconstitution
using the Lef12/2Tcf1(V)2/2 fetal liver precursors resem-
bled that of the fetal thymic organ cultures. These data
suggest that the Lef12/2Tcf1(V)2/2 T cell differentiation
defects are T cell autonomous and are not caused by
the double-deficient thymic stroma.
Figure 4. Lef12/2Tcf1(V)2/2 Fetal Thymic Organ Cultures Retain the
Ability to Mature in Response to Anti-CD3 Antibody Treatment Expression and Rearrangement of the TCRa
Two-color flow cytometry analysis of E17.5 fetal thymic organ cul- Locus Are Severely Impaired in
ture, after 5 days of culture, with or without the addition of 10 mg/
Lef12/2Tcf12/2 Thymocytesml of anti-CD3 antibody. Cells were stained using antibodies against
Rearrangement and expression of the various TCR locimouse CD4 and CD8. Unstimulated wild-type thymic organ cultures
showed a profile similar to that of the wild-type culture in Figure 1. define important regulatorysteps in T cell differentiation.
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Figure 5. Adoptive Transfer Experiments Us-
ing Lef12/2Tcf1(V)2/2 E16.5 Fetal Liver Display
Incomplete T Cell Development
(A) Two-color flow cytometry analysis of thy-
mus derived from adoptive transfer experi-
ments using antibodies against mouse CD4
and CD8. The data shown represent only
successful T cell reconstitution of the total
adoptive transfers using Tcf12/2 fetal liver
precursors (Lef11/2Tcf12/2, 2 of 12, and
Lef12/2Tcf12/2, 1 of 12; see Table 2).
(B) Two-color flow cytometry analysis of pe-
ripheral blood derived from adoptive transfer
experiments using antibodies against mouse
CD4, CD8, IgDb, and IgMb. Tissues were re-
moved 10 weeks after intravenous transfer of
1 3 107 fetal liver cells. Peripheral blood was
collected via tail bleed, and red cells were
lysed with 150 mM NH4Cl, 10 mM KHCO3, and
0.1 mM EDTA.
To gain further insight into the molecular defects in differentiation, whereas rearrangement of the TCRa oc-
curs during theCD41CD81 DP stage (Wilson etal., 1996).Lef12/2Tcf12/2 fetal thymic organ cultures, we analyzed
the mRNA for the presence of transcripts from the TCR The rearrangement status of the TCR loci was examined
by PCR analysis of genomic DNAfrom fetal thymic organloci and from genes that are expressed during earlier T
lymphocyte differentiation, such as those encoding cultures and by probing the DNA blots with TCRa, TCRb,
and TCRd DNA fragments (Figure 6C). Abundant V(D)JADA, CD5, Lck, pTa, RAG-1, and terminal deoxynucleo-
tidyl transferase (TdT). Amplification of cDNA from multi- recombination was observed for both TCRa and TCRb
loci in LEF-1 and in TCF-1±deficient thymocytes. How-ple thymic organ cultures by polymerase chain reaction
(PCR) and visualization of the products by hybridization ever, no rearrangements of Va→Ja at the TCRa locus
were detected in Lef12/2Tcf12/2 fetal thymic organ cul-with specific DNA probes indicated that Lef12/2Tcf1(V)2/2
thymocytes generate transcripts from the ADA, CD5, tures and only a low level of V(D)J recombinations at
the TCRb locus could be visualized on long exposuresLck, pTa, RAG-1, TCRd, and TdT genes but contain
reduced levels of TCRa and TCRb mRNA (Figures 6A of the autoradiogram (data not shown). Abundant TCRd
locus recombination was detected in Lef12/2Tcf12/2 fetaland 6B). By contrast, expression of the TCRa and TCRb
genes was detected at normal levels in fetal thymic thymic organ cultures, demonstrating that V(D)J recom-
bination can occur in the absence of LEF-1 and TCF-1organ cultures from both Lef12/2 and Tcf12/2 single gene
disruptions. (Figure 6C).
The relatively low abundance of transcripts from theExpression of the TCRa and TCRb loci is preceded
by rearrangement of the V, D, and J gene segments. TCRa and TCRb genes in the Lef12/2Tcf12/2 fetal thymic
organ cultures could be due either to the absence ofRearrangement of the TCRb, TCRg, and TCRd loci oc-
curs predominantly in CD442CD251 DN stage of T cell the DP and CD41 and CD81 MSP T cell populations, or
Table 2. Frequency of Lymphocyte Recovery in Adoptive Transfer Experiments
Spleen
No. of Thymus
Donor Recipient Transfers T Cells T Cells B Cells
No donor BALB/c SCID 2 0/2 0/2 0/2
C57BL/6 BALB/c SCID 18 18/18 18/18 18/18
Lef12/2Tcf11/1 BALB/c SCID 36 36/36 36/36 36/36
Lef11/2Tcf1(V)2/2 BALB/c SCID 12 2/12 0/12 12/12
Lef12/2Tcf1(V)2/2 BALB/c SCID 12 1/12 0/12 12/12
All analyses were performed 12 weeks after intravenous transfer of 1 3 107 E16.5 fetal liver cells into BALB/c SCID mice. The presence of T
cells and B cells within the thymus and spleen was detected by fluorescence-activated cell sorting, marking T cells with antibodies against
CD4 and CD8 and B cells with allotype-specific antibodies against IgD and IgM. Adoptive transfers that contained lymphocytes that amounted
to at least 5% of the total tissue were scored as successful reconstitutions.
Immunity
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Figure 6. Analysis of Gene Expression and
TCR Gene Rearrangements in Lef12/2
Tcf1(V)2/2 Fetal Thymic Organ Cultures
(A) Expression of the ADA, CD5, Lck, pTa,
TCRa, TCRb, TCRd, TdT, and RAG-1 genes
in fetal thymic organ cultures. mRNA was
isolated from neonatal thymus or from E17.5
fetal thymic organ cultures after 7 days of
culture. cDNA was generated by reverse tran-
scription (RT) and amplified by PCR, and the
products were separated by gel electropho-
resis and visualized by hybridizing DNA blots
with labeled probes. The genotypes of the
fetal thymic organ cultures were determined
by DNA blot analysis and are indicated above
the autoradiograms of the cDNA products.
(B) Expression of actin was used as a control
for the quality of mRNA and as an estimate
of the quantity of cDNA used in each lane.
To control for a potentialcontamination of the
mRNA preparations by genomic DNA, PCR
reactions were also performed in the absence
of reverse transcription.
(C) Analysis of TCRa, TCRb, and TCRd gene
rearrangements in total fetal thymic organ
cultures from Lef12/2Tcf1(V)-/ mice. PCR was
performed using genomic DNA isolated from
neonatal thymus,head, or E17.5 fetal thymic organ cultures after 7 days of culture. DNA blots of PCR products were hybridized with radiolabeled
oligonucleotides specific for actin or for specific TCRa, TCRb, and TCRd recombination products. Each lane represents an independent organ
culture. Long exposures of the TCRb blot revealed a low level of rearrangement, whereas similar exposures of the TCRa blot did not reveal
any detectable rearrangements.
alternatively, to the absence of gene expression. To but not in cultures from mice carrying single mutations
in either gene alone. Specifically, we show that at leastdistiguish between these possiblities, we repeated our
mRNA analysis with sorted DN and CD81 ISP cells from two steps in the differentiation of a/b T cells are affected
in fetal thymic organ cultures from Lef12/2Tcf12/2 mice.fetal thymic organ cultures of wild-type, Lef12/2,
Tcf1(V)2/2, and Lef12/2Tcf1(V)2/2 embryos (Figure 7). As The differentiation of T cells from CD81 ISP cells to
CD41CD81 DP cells is completely arrested. Moreover,anticipated, TCRa mRNA was undetectable in the DN
fraction of all organ cultures and was present in the an incomplete block at the CD442CD251 DN stage of
development is observed. In contrast, differentiation ofCD81 ISP fraction of the wild-type, Lef12/2, and
Tcf1(V)2/2 organ cultures. However, TCRa mRNA was g/d T cells in the thymus appears to be largely unaf-
fected, suggesting that LEF-1 and TCF-1 specificallygreatly reduced in the Lef12/2Tcf1(V)2/2 CD81 ISP frac-
tion, consistent with the result obtained with the unfrac- regulate differentiation of the a/b T cell lineage.
The observed defects in T cell differentiation in thetionated thymus mRNA. In contrast, TCRb was ex-
pressed at similar levels in the cells of the DN and CD81 double-mutant mice cannot be accounted for by loss
of expression of known presumed target genes for LEF-1ISP T cells of all tested genotypes, including the homo-
zygous double-mutant mice. All DN and CD81 ISP frac- and TCF-1. The incomplete block at the CD442CD251
DN stage of T cell differentiation is similar to the arresttions tested contained equivalent amounts of TCRb
mRNA. Thus, the decrease in TCRb transcription de- of T cell differentiation seen in mice deficient in compo-
nents of the pre-T cell signaling pathway. Mice carryingtected in the unfractioned Lef12/2Tcf12/2 fetal thymic
organ cultures is probably due to the marked reduction targeted gene disruptions in the TCRb locus (Mom-
baerts et al., 1992) have a complete block in differentia-in the absolute number of T cells and the absence of
DP and MSP T cells that normally express TCRa and tion at this stage; however, our analysis suggests that
TCRb transcription is largely unaffected by the absenceTCRb at high levels. The absence of cells representing
the later stages of T cell differentiation may also account of functional LEF-1 and TCF-1. A potential binding site
for LEF-1 and TCF-1 has been identified in the humanfor the modest decreasein the Lef12/2Tcf12/2 fetal thymic
organ cultures in the levels of CD5 and RAG-1 expres- TCRb enhancer (Leiden, 1993), but the functional analy-
sis of both the human and the murine TCRb enhancersion, which are up-regulated in DP T cells.
did not include this transcription factor binding site
(Krimpenfort et al., 1988; Takeda et al., 1990). An incom-Discussion
plete arrest of T cell differentiation at the CD442CD251
DN stage has also been reported in mice carrying muta-In this study we show that the closely related transcrip-
tion factors LEF-1 and TCF-1 regulate T cell differentia- tions in the lck gene (Molina et al., 1992). Although the
promoter of this gene contains a site that is recognizedtion in a partially redundant manner. T cell differentiation
is severely impaired in fetal thymic organ cultures from by LEF-1/TCF-1 in vitro (Allen et al., 1992), the lck gene is
expressed at normal levels in fetal thymic organ culturesmice carrying mutations in both Lef1 and Tcf1 genes,
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transient transfection assays (Travis et al., 1991; Water-
man et al., 1991; Giese et al., 1995; van de Wetering
et al., 1996). Although the LEF-1/TCF-1 binding sites
appear to bedispensable for the activityof a larger TCRa
enhancer fragment in transient transfection assays (Ho
and Leiden, 1990), we found a marked reduction of the
expression and rearrangementof the endogenous TCRa
locus in thymic organ cultures from Lef12/2Tcf12/2 mice.
In addition, our analysis of sorted CD81 ISP T cells
revealed that transcription of the constant region of the
TCRa locus is greatly reduced in the Lef12/2Tcf12/2 mice
but unaffected in either Lef12/2 or Tcf12/2 mice. The
marked decrease in the expression of the TCRa locus
in sorted CD81 ISP T cells, which are present in the
Lef12/2Tcf12/2 mice and contain normal levels of TCRb
transcripts, indicates that LEF-1 and TCF-1 directly con-
trol the expression of the TCRa locus in a redundant
manner. These findings also suggest that the locus con-
trol region, which has been identified in the 39 region of
the TCRa locus (Diaz et al., 1994), either fails to compen-
sate for the functional deficiency of the TCRa enhancer
or involves regulation by LEF-1 and TCF-1.
The complete arrest of differentiation at the CD81 ISP
Figure 7. Analysis of TCRa and TCRb mRNA Expression in DN and
stage in the Lef12/2Tcf12/2 thymocytes cannot yet beCD81 ISP T Cells
accounted for by a change in the expression of known(A) Flow cytometry of thymocytes from E17.5 fetal thymic organ
presumed target genes. However, treatment of fetal thy-cultures after 7 days. Cells weresorted for lack of surface expression
mic organ cultures with an antibody against murineof CD4 (left panel) and CD3 (right panel). Cells that met these criteria
were further sorted for expression of CD8. CD32CD42CD82 cells CD81 appears toproduce defects in T cell differentiation
(right panel, left gate) were used as DN T cells, and CD32CD42CD81 similar to those observed in Lef12/2Tcf12/2 fetal thymic
cells (right panel, right gate) were used as CD81 ISP T cells. organ cultures (Boismenu et al., 1996). Organ cultures
(B) RT-PCR analysis of mRNA from sorted DN and CD81 ISP T cells. treated with anti-CD81 antibodies failed to produce DP
cDNA was prepared from sorted cell populations of the various
cells but generated abundant numbers of CD81 ISPgenotypes and amplified by PCR with primers for either TCRa and
cells. In addition, a second block in T cell differentiationTCRb. The RT-PCR products were visualized by DNA blot analysis
and hybridization with probes for constant region sequences from at the CD251 DN stage was described. The authors
the TCRa and TCRb loci. attributed the block in development to the prevention
of an essential interaction between stromal-expressed
CD81 and an unknown receptor on the surface of the
from Lef12/2Tcf12/2 mice. Finally, mutation of the pTa developing lymphocyte. Given that the adoptive transfer
gene results in an incomplete block at the CD442CD251 experiments with Lef12/2Tcf12/2 precursors demon-
DN stage (Fehling et al., 1995). This gene, however, is strated a similar defect to the Lef12/2Tcf12/2 fetal thymic
also expressed at normal levels in fetal thymic organ organ culture, it is not likely that a deficiency of stromal
cultures from Lef12/2Tcf12/2 mice. Although we cannot CD81 is responsible, but it remains possible that the
rule out the possibility that another component of the receptor for CD81 may be a target of LEF-1 and TCF-1.
pre-T cell receptor signaling pathway is dependent on In comparison with the analysis of adult Tcf12/2 mice
the expression of LEF-1 and TCF-1, our experiment in that revealed an incomplete block at the CD81 ISP stage
which we used an anti-CD3 antibody to stimulate differ- (Verbeek et al., 1995; Ohteki et al., 1996), the fetal thymic
entiation artificially suggests that this pathway may be organ cultures from the Lef12/2Tcf12/2 mice show a full
at least partially intact. arrest of differentiation at thesame developmental stage
Another potential target gene for regulation by LEF-1 and, in addition, a more pronounced block at the earlier
and TCF-1 is the Ada gene encoding the enzyme ADA, CD442CD251 DN stage. Although adoptive transfer ex-
which is required for the proper maturation of devel- periments indicate similar qualitative defects in the ap-
oping thymocytes. Studies of the human ADA enhancer pearance of the different T cell populations within the
have identified a LEF-1/TCF-1 binding site that is impor- thymus, these experiments also reveal a pronounced
tant for the insertion site±independent expression of dependence of T cell reconstitution on TCF-1. This defi-
transgenes in the thymus of transgenic mice (Haynes ciency in reconstitution of T cells could be explained,
et al., 1996). However, the Ada gene is expressed in in principle, by the previously reported defect in the
Lef12/2Tcf12/2 fetal thymic organ cultures at apparently number of actively dividing cells in the thymus of adult
normal levels. Thus, none of these endogenous genes Tcf12/2 mice (Verbeek et al., 1995).
that contain biochemically identified LEF-1/TCF-1 bind- Several mechanisms may account for the differential
ing sites in transcriptional control regions is critically phenotype of the double-mutant and single-mutant
dependent on these transcription factors in vivo. mice. First, LEF-1 and TCF-1 may be functionally redun-
The minimal TCRa enhancer has been shown to be dant. However, a simple redundancy between these
transcription factors is unlikely because Tcf12/2 miceregulated by LEF-1, and to a lesser extent by TCF-1, in
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already display a phenotype that is further augmented for these transcription factors, the absence of TCRa
expression cannot account for the entire T cell pheno-by a mutation in the Lef1 gene. This contrasts with the
redundancy observed in the regulation of other cell lin- type of the Lef12/2Tcf12/2 mice. The identification of
other functionally important genetic targets of theseeages. For example, single targeted gene inactivations
of the myogenic transcription factors genes MyoD and transcription factors may provide insight into the regula-
tory network governing the transcriptional control of TMyf-5 fail to produce an obvious defect in muscle differ-
entiation (Braun et al., 1992; Rudnicki et al., 1992), cell differentiation.
whereas mice carrying mutations in both genes display
a severe defect in muscle formation (Rudnicki et al., Experimental Procedures
1993; reviewed by Lassar and Munsterberg, 1994). The
Micephenotype of the Lef12/2Tcf12/2 mice could be formally
C57BL/6 and BALB/c SCID mice were obtained from Jackson Labo-explained by the difference in the relative abundance
ratories (Bar Harbor, ME) and maintained in the Animal Care Facilityof redundant transcription factors. Consistent with this
at the University of California, San Francisco. LEF-1± and TCF-
scheme, TCF-1 is significantly more abundant than 1±deficient mice were generated as previously described(van Gend-
LEF-1 in the thymus (van de Wetering et al., 1996). Thus, eren et al., 1994; Verbeek et al., 1995). All experimental adult animals
the absence of the abundant transcription factor TCF-1, were 8±12 weeks of age.
but not the absence of the less abundant factor LEF-1,
may result in a partial phenotype in thymic development Fetal Thymic Organ Cultures
Thymi were isolated from embryos at E17.5. Both lobes were placedthat is further impaired by a lack of both factors.
on autoclaved polycarbonate membranes (Costar) suspended byA second potential mechanism could involve a func-
metal grids over the inner well of Falcon 3037 tissue culture platestional synergy between LEF-1 and TCF-1 whereby the
(Falcon). RPMI supplemented with 10% fetal calf serum, sodiumtwo transcription factors regulate distinct cellular pro-
pyruvate, penicillin/streptomycin, nonessential amino acids, vita-
cesses that together are required for normal T cell differ- mins, and 2-mercaptoethanol was used as culture medium in the
entiation. According to this view, LEF-1 and TCF-1 inner well, maintaining contact with the bottom surface of the mem-
brane only. Phosphate-buffered saline (PBS) was used in the outerwould regulate separate sets of target genes. Although
well to maintain a humid environment. Organ cultures were kept atthe two transcription factors can bind the same sites in
378C with 5.0% CO2 for 7 days. Medium was replaced each dayvitro and display sequence homology outside the HMG
during this period. After culture, lobes were dispersed and cellsdomain, both proteins also contain distinct domains that
were filtered over nylon membrane. Stimulation of organ cultures
account for differential transcriptional activation poten- with anti-CD3e antibody (145±2C11, 10 mg/ml) was performed by
tials. For example, LEF-1 contains a context-dependent adding antibody at the start of culture and analysis of antibody
treated and untreated cultures was performedafter 5 days of culture.transcriptional activation domain (Carlsson et al., 1993;
For the anti-CD3e experiments, the media was not changed duringGiese and Grosschedl, 1993) that interacts with an ubiq-
the course of culture.uitously expressed nuclear protein, ALY (Bruhn et al.,
1997). In addition to association with LEF-1, ALY also
Adoptive Transfersinteracts with the transcription factor AML-1, which rec-
Fetal liver was isolated from E16.5 embryos and dispersed by stan-ognizes two sites adjacent to the LEF-1 binding site in
dard methods. The resultant suspension was then filtered over ny-
the TCRa enhancer (Bruhn et al., 1997). ALY is required lon, and cells were resuspended at 1 3 108cells/ml in RPMI 1 10%
for TCRa enhancer function, and it interacts with LEF-1 fetal calf serum. BALB/c SCID mice (Jackson Laboratories) were
more efficiently than with TCF-1 (Bruhn et al., 1997), used as recipients in all experiments. Fetal liver cells (1 3 107) were
injected intravenously into the tail vein of each mouse, and transferwhich may account for the more efficient activation of
recipients were sacrificed after 10 weeks.the minimal TCRa enhancer by LEF-1 (van de Wetering
et al., 1996).
Flow CytometryRecently, studies have shown that LEF-1 and TCF-1,
Cells (1 3 107) were resuspended in 25 ml of staining medium (PBSin association with b-catenin, can mediate transcrip-
1 0.3% bovine serum albumin) and incubated with antibody for 15
tional activation independent of a specific context of min. Cells were then washed three times with staining medium,
other transcriptional factor binding sites (van de Weter- and the process was then repeated with secondary antibodies as
ing et al., 1997). However, this association of LEF-1/ necessary. After staining, cells were resuspended in 400 ml of stain-
ing medium with 200 ng/ml propidium iodine. Cells were then ana-TCF-1 with b-catenin may not be important for the regu-
lyzed using either a FACStar Plus (Becton Dickinson), a FACSCaliburlation of the TCRa enhancer because b-catenin does
(Becton Dickinson), or a modified dual-laser FACS II (FLASHER,not affect LEF-1±mediated transcriptional stimulation of
Stanford Shared FACS Facility, Stanford, CA). Data generated wasthe TCRa enhancer (Behrens et al., 1996). Moreover, the
interpreted using Cellquest (Becton Dickinson) for experiments per-
HMG domain of LEF-1 lacking the N-terminal b-catenin formed on the FACStar plus and the FACSCalibur or using FACS-
interaction domain and truncated isoforms of TCF-1 DESK (Stanford Shared FACS Facility) for data collected on
stimulate the activity of the TCRa enhancer (Giese et FLASHER. Data shown in the figures are gated for lymphocytes by
size and complexity and for live cells by excluding cells that uptakeal., 1995; van de Wetering et al., 1996). The role of Wnt
propidium iodine. Plots display 5% probability or dot plot represen-signaling in thymic T cell differentiation remains unclear,
tation.but b-catenin:LEF-1/TCF-1 complexes may be respon-
sible for regulating some of the phenotypes observed
Antibodiesin the Lef12/2Tcf12/2 fetal thymic organ cultures.
Directly conjugated antibodies specific for mouse B220, CD3e, CD4,
In conclusion, the transcription factors LEF-1 and CD8, TCRb, and TCRg/d were obtained from Caltag (San Francisco,
TCF-1 play an important and at least partially redundant CA). Directly conjugated antibodies specific for mouse CD25, CD44,
role in T cell differentiation and in the regulation of the IgDb, IgMb, NK1.1, Thy1.2, and streptavidin-conjugated allophycoer-
ythrin were obtained from Pharmingen (La Jolla, CA).TCRa locus. Although the TCRa gene is a likely target
Role of LEF-1 and TCF-1 in T Cell Differentiation
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RNA and DNA Isolation and Analysis Aronow, B., Silbiger, R., Dusing, M., Stock, J., Yager, K., Potter, S.,
Hutton, J., and Wiginton, D. (1992). Functional analysis of the humanTotal mRNA and DNA were obtained from whole fetal thymic organ
cultures using TRIzol (BRL) and mRNA from sorted cells was gener- adenosine deaminase gene thymic regulatory region and its ability
to generate position-independent transgene expression. Mol. Cell.ated by using an mRNA capture kit (Boehringer Mannheim); both
products were used according to manufacturers' recommendations Biol. 12, 4170±4185.
with no modifications. Half of the mRNA was used for cDNA produc- Behrens, J., von Kries, J.P., KuÈ hl, M., Bruhn, L., Wedlich, D.,
tion with 200 nM random hexamers (Pharmacia) and reverse tran- Grosschedl, R., and Birchmeier, W. (1996). Functional interaction of
scriptase (Boehringer Mannheim) in commercial buffer (Boehringer b-catenin with the transcription factor LEF-1. Nature 382, 638±642.
Mannheim) modified by the addition of 3 U RNasin. Reactions were Boismenu, R., Rhein, M., Fischer, W.H., and Havran, W.L. (1996). A
incubated for 60 min at 378C. Reverse transcriptase (RT)±PCR ampli- role for CD81 in early T cell development. Science 271, 198±200.
fication of cDNA was performed in 10 ml total volume with 1 mM
Braun, T., Rudnicki, M.A., Arnold, H., and Jaenisch, R. (1992). Tar-primers, 0.2 mM dNTP, and 0.5 U Taq polymerase (Boehringer Mann-
geted inactivation of the muscle regulatory gene myf-5 results inheim) in Taq polymerase buffer. All RT-PCR reactions, except for
abnormal rib development and perinatal death. Cell 71, 369±382.the ADA RT-PCR, were normalized for actin and were performed
Brickner, A.G., Gossage, D.L., Dusing, M.R., and Wiginton, D.A.under the following amplification conditions: 45 s at 948C, 45 s at
(1995). Identification of a murine homolog of the human adenosine618C, and 1 min at 728C. ADA RT-PCR was modified to 45 s at 94C,
deaminase thymic enhancer. Gene 167, 261±266.45 s at 578C, and 1 min at 728C. Actin RT-PCR was performed for
30 cycles, and all other RT-PCR procedures used 35 cycles. Geno- Bruhn, L., Munnerlyn, A., and Grosschedl, R. (1997). ALY, a context-
mic PCR was performed under identical reaction conditions and dependent coactivator of LEF-1 and AML-1, is required for TCRa
used the following amplification protocol: 75 s at 948C, 75 s at 628C, enhancer function. Genes Dev. 11, 640±653.
and 90 s at 728C, for 30 cycles. Carlsson, P., Waterman, M.L., and Jones, K.A. (1993). The hLEF/
PCR products were transferred to Hybond N1 (Amersham) nylon- TCF-1a HMG protein contains a context-dependent transcriptional
supported nitrocellulose for 8±12 hr. Prehybridization/hybridization
activation domain that induces the TCRa enhancer in T cells. Genes
was done at 658C overnight in 63 saline±sodium citrate, 53 Denh-
Dev. 7, 2418±2430.
arts, 0.1% sodium dodecyl sulfate, and 0.5 mg/ml salmon sperm
Carroll, A.M., and Bosma, M.J. (1991). T-lymphocyte developmentDNA. RAG-1, CD5, TdT, and actin were hybridized with random
in scid mice is arrested shortly after the initiation of T-cell receptorprimed cDNA, and all other probes used were end-labeled oligonu-
d gene recombination. Genes Dev. 5, 1357±1366.cleotides. Oligonucleotides used for RT-PCR and generation of
probes are as follows: actin sense, GTTTGAGACCTTCAACACC; ac- Clevers, H., and Grosschedl, R. (1996). Transcriptional control of
tin antisense, GTGGCCATCCCTGCTCGAAGTC; ADA (probe), GAGA lymphoid development: lessons from gene targeting. Immunol. To-
CCATTGAAGGAAGTAGCCTC; ADA sense, GAAGTACAATCAGGAG day 17, 336±343.
ACCCGTGG; ADA antisense, CTGTTGTAGAGAGCTTCATCCTCG; Clevers, H., Oosterwegel, M.A., and Georgopoulos, K. (1993). Tran-
CD5 sense, TTCTGCCTCGGACAGTCTGG; CD5 antisense, GCCTGT scription factors in early T cell development. Immunol. Today 14,
CCTTGGCCTTGTAG; Lck (probe), GCAGCTGCTTCATGAGGTT 591±596.
AGC; Lck sense, GGTCAGAGACTTCGACCAGAAC; Lck antisense,
Diaz, P., Cado, D., and Winoto, A. (1994). A locus control region in
CCACTGCATAAAGCCGGACTAG; pTa (probe), AGTTTGAAGAGGA
the T cell receptor a/d locus. Immunity 1, 207±217.
GCAGGCGCAG; pTa sense, CACACTGCTGGTAGATGGAAGGC;
Fehling, H.J., Krotkova, A., Saint-Ruf, C., and von Boehmer, H.pTa antisense, GTCAGGAGCACATCGAGCAGAAG; RAG-1 sense,
(1995). Crucial role of the pre-T-cell receptor a gene in the develop-TGCAGACATTCTAGCACTCTGG; RAG-1 antisense, ACATCTGCCT
ment of ab but not gd T cells. Nature 375, 795±798.TCACGTCGAT; TCRa (probe), TTCTCAGTCAACGTGGCATCACA;
TCRa sense, CCAGAACCTGCTGTGTACCAGTT; TCRa antisense, Fulop, G.M., and Phillips, R.A. (1986). Full reconstitution of the im-
ACAGCCTCAGCGTCATGAGCAG; TCRb (probe), TTCAGAGGAGGA mune deficiency in scid mice with normal stem cells requires low-
CAAGTGGC; TCRb sense, AAAGGCTACCCTCGTGTGC; TCRb anti- dose irradiation of the recipients. J. Immunol. 136, 4438±4443.
sense, GGATGGTTGCAGACAGAACC; TCRd (probe), ACCCTAAAG Giese, K., and Grosschedl, R. (1993). LEF-1 contains an activation
AGGTGACTATAAGTC; TCRd sense, GGAACAAATGTTGCTTGTCTG domain that stimulates transcription only in a specific context of
GTG; TCRd antisense, AATGGTCTTGGCAAACAGCAGTCG; TdT factor-binding sites. EMBO J. 12, 4667±4676.
sense, GAAGATGGGAACAACTCGAAGAG; and TdT antisense, GAC
Giese, K., Cox, J., and Grosschedl, R. (1992). The HMG-domain of
GTGCTGGAACATTCTGGGAG. lymphoid enhancer factor 1 bends DNA and facilitates assembly of
Oligonucleotides used for TCR gene rearrangement assays are functional nucleoprotein structures. Cell 69, 185±195.
as follows (Carroll and Bosma, 1991; Levin et al., 1993): JaTT11
Giese, K., Kingsley, C., Kirshner, J.R., and Grosschedl, R. (1995).(probe), GAAAGCAGAGTCCCAATTCCAAAG; JaTT11±39, GACCCT
Assembly and function of a TCR a enhancer complex is dependentATTACTCACATACTTGGCTTG; Va2C-59, ACTGTCTCTGAAGGAGC
on LEF-1-induced DNA bending and multiple protein-protein inter-CTCTCTG; VaF3±59, ACCCAGACAGAAGGCCTGGTCACT; VaH-59,
actions. Genes Dev. 9, 995±1008.CAGAAGGTGCAGCAGAGCCCAGAA; JB2 (probe), TTTCCCTCCCG
Godfrey, D.I., and Zlotnik, A. (1993). Control points in early T cellGAGATTCCCTAA; JB2±39, TGAGAGCTGTCTCCTACTATCGATT;
development. Immunol. Today 14, 547±553.VB12±59, AGTTACCCAGACACCCAGACATGA; JdH (probe), GGAAG
CTTACTTCCAACCTCTTTAGGT; Vd-59, GGGGGATCCTGCCTCCTT Godfrey, D.I., Kennedy, J., Mombaerts, P., Tonegawa, S., and Zlot-
CTAC; and Jd1±39, AAAAAGCTTACTCAACACGACTGGA. nik, A. (1994). Onset of TCR-b gene rearrangement and the role of
TCR-b expression during CD32CD42CD82 thymocyte differentia-
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